How many institutions held ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value in Q2 2020?

56 institutional investors reported ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value for Q2 2020. Use the holders table for investor-level position and value details.

Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)

Q: What does CUSIP 00461U105 represent in this 13F holders report?

CUSIP 00461U105 is the security identifier for ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value used to aggregate holder disclosures.

CUSIP: 00461U105

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock, $0.00001 par value
Shares outstanding: 140,909,091
Total 13F shares: 28,456,883
Share change: -3,663,878
Total reported value: $46,099,261
Price per share: $1.62
Number of holders: 56
Value change: -$5,512,533
Number of buys: 20
Number of sells: 41

Quarterly Holders Quick Answers

What is CUSIP 00461U105?
CUSIP 00461U105 identifies ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 00461U105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
MFN Partners Management, LP	13F	Company	2.8%	4,000,000	$4,160,000	—	31 Mar 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	2.3%	3,175,636	$3,303,000	—	31 Mar 2020	13F
BlackRock Finance, Inc.	13F	Company	1.9%	2,626,521	$2,732,000	—	31 Mar 2020	13F
Endurant Capital Management LP	13F	Company	1.9%	2,619,187	$2,724,000	—	31 Mar 2020	13F
Samsara BioCapital, LLC	13F	Company	1.9%	2,608,117	$2,712,000	—	31 Mar 2020	13F
EcoR1 Capital, LLC	13F	Company	1.5%	2,087,312	$2,171,000	—	31 Mar 2020	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	1.4%	2,000,000	$2,080,000	—	31 Mar 2020	13F
Sofinnova Investments, Inc.	13F	Company	1.4%	1,911,573	$1,988,000	—	31 Mar 2020	13F
Vivo Capital, LLC	13F	Company	1.2%	1,647,214	$1,713,000	—	31 Mar 2020	13F
Rock Springs Capital Management LP	13F	Company	1.1%	1,600,000	$1,664,000	—	31 Mar 2020	13F
Parkman Healthcare Partners LLC	13F	Company	1.1%	1,537,357	$1,599,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	0.99%	1,400,454	$1,457,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	0.47%	667,188	$694,000	—	31 Mar 2020	13F
Aisling Capital Management LP	13F	Company	0.45%	634,455	$660,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.42%	587,094	$610,000	—	31 Mar 2020	13F
Telemetry Investments, L.L.C.	13F	Company	0.36%	501,000	$521,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.25%	355,127	$370,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.15%	217,782	$227,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	0.15%	206,784	$215,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.13%	179,044	$186,000	—	31 Mar 2020	13F
WINTON GROUP Ltd	13F	Company	0.08%	115,839	$120,000	—	31 Mar 2020	13F
Invesco Ltd.	13F	Company	0.08%	114,757	$119,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.08%	110,000	$115,000	—	31 Mar 2020	13F
Alambic Investment Management, L.P.	13F	Company	0.07%	98,286	$102,000	—	31 Mar 2020	13F
Man Group plc	13F	Company	0.07%	93,518	$97,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.06%	84,702	$89,000	—	31 Mar 2020	13F
HighTower Advisors, LLC	13F	Company	0.05%	69,635	$72,000	—	31 Mar 2020	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.04%	58,726	$61,000	—	31 Mar 2020	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.04%	57,155	$59,000	—	31 Mar 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.04%	55,200	$57,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.04%	52,350	$54,000	—	31 Mar 2020	13F
RHUMBLINE ADVISERS	13F	Company	0.04%	51,626	$54,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.04%	51,250	$53,000	—	31 Mar 2020	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.03%	47,336	$49,000	—	31 Mar 2020	13F
Cambridge Investment Research Advisors, Inc.	13F	Company	0.03%	44,700	$46,000	—	31 Mar 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.03%	39,023	$41,000	—	31 Mar 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.02%	34,700	$36,000	—	31 Mar 2020	13F
Creative Planning	13F	Company	0.02%	30,076	$31,000	—	31 Mar 2020	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.02%	29,649	$31,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.02%	24,086	$25,000	—	31 Mar 2020	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.02%	22,266	$23,000	—	31 Mar 2020	13F
UBS Group AG	13F	Company	0.01%	18,997	$20,000	—	31 Mar 2020	13F
Aperio Group, LLC	13F	Company	0.01%	18,566	$19,000	—	31 Mar 2020	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.01%	18,418	$19,000	—	31 Mar 2020	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	18,241	$19,000	—	31 Mar 2020	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.01%	18,150	$19,000	—	31 Mar 2020	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.01%	16,490	$17,000	—	31 Mar 2020	13F
WEDBUSH SECURITIES INC	13F	Company	0.01%	14,000	$15,000	—	31 Mar 2020	13F
SG Americas Securities, LLC	13F	Company	0.01%	13,280	$14,000	—	31 Mar 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.01%	11,413	$12,000	—	31 Mar 2020	13F

Institutional Holders of Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS) as of Q2 2020

As of 30 Jun 2020, Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,456,883 shares. The largest 10 holders included MFN Partners Management, LP, RENAISSANCE TECHNOLOGIES LLC, Samsara BioCapital, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Sofinnova Investments, Inc., Endurant Capital Management LP, Parkman Healthcare Partners LLC, Vivo Capital, LLC, Rock Springs Capital Management LP, and EcoR1 Capital, LLC. This page lists 56 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

Q2 2020 holders

Holder diff

-9

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.